Variant report

Variant	nsv9719
Chromosome Location	chr19:39260214-39262452
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr19:39260633-39260724	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCL3	chr19:39260146-39260863	A549	lung:	n/a	chr19:39260547-39260560
3	BCLAF1	chr19:39260404-39260725	GM12878	blood:	n/a	chr19:39260547-39260560
4	BHLHE40	chr19:39260480-39260797	GM12878	blood:	n/a	chr19:39260550-39260566
5	CBX3	chr19:39260336-39260750	K562	blood:	n/a	n/a
6	CHD2	chr19:39260543-39260598	H1-hESC	embryonic stem cell:	n/a	n/a
7	CREB1	chr19:39260295-39260842	A549	lung:	n/a	n/a
8	CTCF	chr19:39260460-39260610	GM06990	blood:	n/a	chr19:39260556-39260565
9	CTCF	chr19:39261354-39261451	NHEK	skin:	n/a	chr19:39261362-39261370
10	CTCF	chr19:39260480-39260630	HCPEpiC	choroid plexus:	n/a	chr19:39260556-39260565
11	CTCF	chr19:39260762-39260833	GM13977	blood:	n/a	n/a
12	CTCF	chr19:39260520-39260670	GM12874	blood:	n/a	chr19:39260556-39260565
13	CTCF	chr19:39260480-39260630	HPAF	blood vessel:	n/a	chr19:39260556-39260565
14	CTCF	chr19:39260365-39260749	IMR90	lung:	n/a	chr19:39260556-39260565
15	CTCF	chr19:39260500-39260650	MCF-7	breast:	n/a	chr19:39260556-39260565
16	CTCF	chr19:39260620-39260770	HAc	cerebellar:	n/a	n/a
17	CTCF	chr19:39260440-39260590	HCM	heart:	n/a	chr19:39260556-39260565
18	CTCF	chr19:39260356-39260776	H1-hESC	embryonic stem cell:	n/a	chr19:39260556-39260565
19	CTCF	chr19:39260560-39260710	BE2_C	brain:	n/a	n/a
20	CTCF	chr19:39260320-39260470	WI-38	lung:	n/a	n/a
21	CTCF	chr19:39260460-39260610	HEEpiC	esophagus:	n/a	chr19:39260556-39260565
22	CTCF	chr19:39260476-39260647	MCF-7	breast:	n/a	chr19:39260556-39260565
23	CTCF	chr19:39260480-39260630	HBMEC	blood vessel:	n/a	chr19:39260556-39260565
24	CTCF	chr19:39260500-39260650	GM12871	blood:	n/a	chr19:39260556-39260565
25	CTCF	chr19:39260469-39260614	SK-N-SH_RA	brain:	n/a	chr19:39260556-39260565
26	CTCF	chr19:39260763-39260809	GM10266	blood:	n/a	n/a
27	CTCF	chr19:39261759-39261808	GM12892	blood:	n/a	n/a
28	CTCF	chr19:39260480-39260630	GM12864	blood:	n/a	chr19:39260556-39260565
29	CTCF	chr19:39260480-39260630	AoAF	blood vessel:	n/a	chr19:39260556-39260565
30	CTCF	chr19:39260500-39260650	WI-38	lung:	n/a	chr19:39260556-39260565
31	CTCF	chr19:39260480-39260630	HMF	breast:	n/a	chr19:39260556-39260565
32	CTCF	chr19:39260440-39260590	RPTEC	kidney:	n/a	chr19:39260556-39260565
33	CTCF	chr19:39260444-39260647	Hela-S3	cervix:	n/a	chr19:39260556-39260565
34	CTCF	chr19:39260340-39260630	HUVEC	blood vessel:	n/a	chr19:39260556-39260565
35	CTCF	chr19:39260358-39260724	A549	lung:	n/a	chr19:39260556-39260565
36	CTCF	chr19:39260429-39260657	A549	lung:	n/a	chr19:39260556-39260565
37	CTCF	chr19:39260375-39260853	GM19238	blood:	n/a	chr19:39260556-39260565
38	CTCF	chr19:39260425-39260675	A549	lung:	n/a	chr19:39260556-39260565
39	CTCF	chr19:39260401-39260725	NHEK	skin:	n/a	chr19:39260556-39260565
40	CTCF	chr19:39260500-39260650	GM12866	blood:	n/a	chr19:39260556-39260565
41	CTCF	chr19:39261630-39261832	Spleen_OC	spleen:	n/a	n/a
42	CTCF	chr19:39260472-39260619	HepG2	liver:	n/a	chr19:39260556-39260565
43	CTCF	chr19:39260480-39260630	AG10803	skin:	n/a	chr19:39260556-39260565
44	CTCF	chr19:39260412-39260698	H1-hESC	embryonic stem cell:	n/a	chr19:39260556-39260565
45	CTCF	chr19:39260500-39260650	GM12869	blood:	n/a	chr19:39260556-39260565
46	CTCF	chr19:39260160-39260310	HFF	foreskin:	n/a	n/a
47	CTCF	chr19:39260448-39260643	LNCaP	prostate:	n/a	chr19:39260556-39260565
48	CTCF	chr19:39260425-39260692	GM13976	blood:	n/a	chr19:39260556-39260565
49	CTCF	chr19:39260773-39260835	NHEK	skin:	n/a	n/a
50	CTCF	chr19:39260406-39260718	GM10266	blood:	n/a	chr19:39260556-39260565

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:39260460-39260510	HUVEC	blood vessel:	n/a
2	chr19:39261921-39261971	HCPEpiC	choroid plexus:	n/a
3	chr19:39260460-39260510	ECC-1	luminal epithelium:	n/a
4	chr19:39260304-39260354	HRPEpiC	eye:	n/a
5	chr19:39260304-39260354	SK-N-SH	brain:	n/a
6	chr19:39260954-39261004	ovcar-3	ovarian:	n/a
7	chr19:39261921-39261971	NH-A	brain:	n/a
8	chr19:39260460-39260510	MCF-7	breast:	n/a
9	chr19:39260460-39260510	BJ	skin:	n/a
10	chr19:39260460-39260510	AG10803	skin:	n/a
11	chr19:39261921-39261971	HEEpiC	esophagus:	n/a
12	chr19:39260304-39260354	MCF10A-Er-Src	breast:	n/a
13	chr19:39260954-39261004	HIPEpiC	eye:	n/a
14	chr19:39260304-39260354	Jurkat	blood:	n/a
15	chr19:39260954-39261004	GM19239	blood:	n/a
16	chr19:39261921-39261971	IMR90	lung:	fetal
17	chr19:39261921-39261971	SKMC	muscle:	n/a
18	chr19:39260954-39261004	HNPCEpiC	eye:	n/a
19	chr19:39261921-39261971	ECC-1	luminal epithelium:	n/a
20	chr19:39260460-39260510	BE2_C	brain:	n/a
21	chr19:39260954-39261004	GM06990	blood:	n/a
22	chr19:39261921-39261971	HepG2	liver:	n/a
23	chr19:39261921-39261971	GM12878	blood:	n/a
24	chr19:39261921-39261971	HIPEpiC	eye:	n/a
25	chr19:39260304-39260354	ovcar-3	ovarian:	n/a
26	chr19:39260460-39260510	CMK	blood:	n/a
27	chr19:39260304-39260354	NB4	blood:	n/a
28	chr19:39260304-39260354	AG09319	gingival:	n/a
29	chr19:39260460-39260510	AG04449	skin:	fetal
30	chr19:39260954-39261004	NH-A	brain:	n/a
31	chr19:39260460-39260510	HAEpiC	amniotic membrane:	n/a
32	chr19:39260954-39261004	SKMC	muscle:	n/a
33	chr19:39260954-39261004	CMK	blood:	n/a
34	chr19:39260304-39260354	HL-60	blood:	n/a
35	chr19:39260460-39260510	HRE	kidney:	n/a
36	chr19:39260954-39261004	T-47D	breast:	n/a
37	chr19:39260460-39260510	T-47D	breast:	n/a
38	chr19:39260460-39260510	PANC-1	pancreas:	n/a
39	chr19:39261921-39261971	GM12891	blood:	n/a
40	chr19:39260460-39260510	PrEC	prostate:	n/a
41	chr19:39261921-39261971	PrEC	prostate:	n/a
42	chr19:39260954-39261004	IMR90	lung:	fetal
43	chr19:39261921-39261971	U87	brain:	n/a
44	chr19:39260954-39261004	K562	blood:	n/a
45	chr19:39261921-39261971	PFSK-1	brain:	n/a
46	chr19:39260460-39260510	AG09309	skin:	n/a
47	chr19:39260954-39261004	NHBE	bronchial:	n/a
48	chr19:39260304-39260354	ECC-1	luminal epithelium:	n/a
49	chr19:39260304-39260354	A549	lung:	n/a
50	chr19:39260460-39260510	HCPEpiC	choroid plexus:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr19:39260117..39262134-chr19:39341376..39343069,2	K562	blood:
2	chr19:39260065..39260751-chr19:39420671..39421390,2	MCF-7	breast:

Variant related genes	Relation type
CAPN12	TF binding region
CAPN12	CpG island
ENSG00000128626	chromatin interactions
ENSG00000104835	chromatin interactions
ENSG00000104824	chromatin interactions

Extended variants
information (count: 56 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:56 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs552737651	chr19:39260221-39260222	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs35061252	chr19:39260279-39260280	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs1471432	chr19:39260282-39260283	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
4	rs564011923	chr19:39260300-39260301	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs575874275	chr19:39260307-39260308	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs546454136	chr19:39260313-39260314	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs564551682	chr19:39260365-39260366	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs528644314	chr19:39260369-39260370	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs374185216	chr19:39260425-39260426	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs62121381	chr19:39260433-39260434	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs1966961	chr19:39260470-39260471	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs529293932	chr19:39260508-39260509	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs548162402	chr19:39260534-39260535	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs4547457	chr19:39260544-39260545	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs367820832	chr19:39260548-39260549	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs1966962	chr19:39260589-39260590	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
17	rs551979983	chr19:39260598-39260599	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs141977093	chr19:39260629-39260630	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs534451184	chr19:39260651-39260652	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs553040974	chr19:39260666-39260667	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs9304579	chr19:39260682-39260683	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
22	rs200834491	chr19:39260693-39260694	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs557356148	chr19:39260695-39260696	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs9304580	chr19:39260702-39260703	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs146288895	chr19:39260710-39260711	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs138327590	chr19:39260724-39260725	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs376980241	chr19:39260752-39260753	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs573488465	chr19:39260771-39260772	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs182351317	chr19:39260772-39260773	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs562234866	chr19:39260791-39260792	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs62121405	chr19:39260904-39260905	Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs369920884	chr19:39260907-39260908	Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs12972514	chr19:39260908-39260909	Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs10402488	chr19:39260913-39260914	Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs530757930	chr19:39260952-39260953	Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs12974327	chr19:39260970-39260971	Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs12972557	chr19:39260996-39260997	Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs528273083	chr19:39261001-39261002	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs546350423	chr19:39261008-39261009	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs568182050	chr19:39261035-39261036	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs58573994	chr19:39261089-39261090	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs57652508	chr19:39261153-39261154	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs369109601	chr19:39261187-39261188	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs201913032	chr19:39261207-39261208	Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs569563195	chr19:39261211-39261212	Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs540100268	chr19:39261533-39261534	Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs558494064	chr19:39261887-39261888	Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs573450144	chr19:39261896-39261897	Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs540841124	chr19:39261936-39261937	Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs199898116	chr19:39261949-39261950	Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Wilms tumour	21544195	CNVD
Mental retardation	19951919	CNVD
19q13.11 deletion syndrome	22378287	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Lung cancer	21569311	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:188 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:39246400-39270800	Weak transcription	K562	blood
2	chr19:39254200-39265400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr19:39259800-39260400	Enhancers	Breast Myoepithelial Primary Cells	Breast
4	chr19:39259800-39260600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
5	chr19:39259800-39261000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr19:39259800-39261000	Enhancers	Placenta Amnion	Placenta Amnion
7	chr19:39260000-39260400	Enhancers	Primary hematopoietic stem cells short term culture	blood
8	chr19:39260000-39260400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
9	chr19:39260000-39260400	Enhancers	Esophagus	oesophagus
10	chr19:39260000-39260400	Flanking Active TSS	GM12878-XiMat	blood
11	chr19:39260000-39260400	Flanking Active TSS	NHEK	skin
12	chr19:39260000-39260600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr19:39260000-39261000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
14	chr19:39260000-39261000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr19:39260000-39261000	Enhancers	Lung	lung
16	chr19:39260000-39261000	Enhancers	Pancreas	Pancrea
17	chr19:39260000-39261000	Active TSS	Rectal Mucosa Donor 29	rectum
18	chr19:39260000-39261000	Enhancers	Stomach Mucosa	stomach
19	chr19:39260000-39261000	Enhancers	Spleen	Spleen
20	chr19:39260000-39261000	Enhancers	HMEC	breast
21	chr19:39260200-39260400	Enhancers	H1 Cell Line	embryonic stem cell
22	chr19:39260200-39260400	Enhancers	HUES6 Cell Line	embryonic stem cell
23	chr19:39260200-39260400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
24	chr19:39260200-39260400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
25	chr19:39260200-39260400	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
26	chr19:39260200-39260400	Flanking Active TSS	Primary B cells from peripheral blood	blood
27	chr19:39260200-39260400	Flanking Active TSS	Primary hematopoietic stem cells	blood
28	chr19:39260200-39260400	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
29	chr19:39260200-39260400	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
30	chr19:39260200-39260400	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
31	chr19:39260200-39260400	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
32	chr19:39260200-39260400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
33	chr19:39260200-39260400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr19:39260200-39260400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
35	chr19:39260200-39260400	Enhancers	Brain Anterior Caudate	brain
36	chr19:39260200-39260400	Flanking Active TSS	Duodenum Mucosa	Duodenum
37	chr19:39260200-39260400	Bivalent Enhancer	Fetal Brain Male	brain
38	chr19:39260200-39260400	Flanking Bivalent TSS/Enh	Fetal Stomach	stomach
39	chr19:39260200-39260400	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
40	chr19:39260200-39260400	Enhancers	Skeletal Muscle Female	skeletal muscle
41	chr19:39260200-39260400	Flanking Bivalent TSS/Enh	Stomach Smooth Muscle	stomach
42	chr19:39260200-39260400	Flanking Active TSS	Thymus	Thymus
43	chr19:39260200-39260600	Enhancers	iPS-18 Cell Line	embryonic stem cell
44	chr19:39260200-39260600	Active TSS	iPS-20b Cell Line	embryonic stem cell
45	chr19:39260200-39260600	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
46	chr19:39260200-39260600	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
47	chr19:39260200-39260600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
48	chr19:39260200-39260600	Enhancers	Adipose Nuclei	Adipose
49	chr19:39260200-39260600	Bivalent Enhancer	Brain Germinal Matrix	brain
50	chr19:39260200-39260600	Active TSS	Duodenum Smooth Muscle	Duodenum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links